The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

AS Martin Griffiths lay in his hospital bed in an induced coma, his family and friends thought: “This is it.” All 21 of them ...

Mazda has an extensive collection of concept cars. Some of these models tried to introduce the Mazda moniker to the world of ...

In late January 2025, news outlets reported on an outbreak of tuberculosis (TB) in the Kansas City, Kansas, area. According ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

The United States is facing one of the largest recorded outbreaks in U.S. history, according to local health officials and ...